Ocular Toxoplasmosis: Advances in <i>Toxoplasma gondii</i> Biology, Clinical Manifestations, Diagnostics, and Therapy

• 出版年: Pathogens
• 主要な著者: Miki Miyagaki, Yuan Zong, Mingming Yang, Jing Zhang, Yaru Zou, Kyoko Ohno-Matsui, Koju Kamoi
• フォーマット: 論文
• 言語: 英語
• 出版事項: MDPI AG 2024-10-01
• 主題: <i>Toxoplasma gondii</i>; Ocular toxoplasmosis; Diagnostic techniques; Pathogenesis research
• オンライン･アクセス: https://www.mdpi.com/2076-0817/13/10/898

<i>Toxoplasma gondii</i>, an obligate intracellular parasite, is a globally prevalent pathogen capable of infecting a wide range of warm-blooded animals, including humans. Ocular toxoplasmosis (OT), a severe manifestation of <i>T. gondii</i> infection, can lead to potentially blinding complications. This comprehensive review delves into the current understanding of <i>T. gondii</i> biology, exploring its complex life cycle, diverse transmission routes, and strain diversity. This article provides an in-depth analysis of the clinical manifestations of OT, which can result from both congenital and acquired infections, presenting a spectrum of signs and symptoms. The review examines various diagnostic strategies employed for OT, including clinical examination, multimodal imaging techniques such as fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), optical coherence tomography (OCT), and optical coherence tomography angiography (OCTA), as well as laboratory tests including serology and molecular methods. Despite extensive research, the specific mechanisms underlying ocular involvement in <i>T. gondii</i> infection remain elusive, and current diagnostic options have limitations. Moreover, the treatment of active and recurrent OT remains a challenge. While existing therapies, such as antimicrobial agents and immunosuppressants, can control active infections, they do not offer a definitive cure or completely prevent recurrence. The clinical endpoints for the management of active and recurrent OT are also not yet well-established, and the available treatment methods carry the potential for adverse effects. This article highlights the need for future research to elucidate the pathogenesis of OT, investigate genetic factors influencing susceptibility to infection, and develop more sensitive and specific diagnostic tools. Enhancing global surveillance, implementing robust prevention strategies, and fostering multidisciplinary collaborations will be crucial in reducing the burden of OT and improving patient outcomes. This comprehensive review aims to provide a valuable resource for clinicians, researchers, and policymakers, contributing to a better understanding of <i>T. gondii</i> infection and its impact on ocular health.